<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2687-0940</journal-id><journal-title-group><journal-title>Challenges in modern medicine</journal-title></journal-title-group><issn pub-type="epub">2687-0940</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2687-0940-2020-43-2-206-215</article-id><article-id pub-id-type="publisher-id">22</article-id><article-categories><subj-group subj-group-type="heading"><subject>CARDIOLOGY</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;MYOCARDIAL INFARCTION AND COMBORBIDITY IN PATIENTS OF YOUNG AND MIDDLE AGES: EXPERIENCE OF THE REGIONAL VASCULAR CENTER&lt;/strong&gt;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;MYOCARDIAL INFARCTION AND COMBORBIDITY IN PATIENTS OF YOUNG AND MIDDLE AGES: EXPERIENCE OF THE REGIONAL VASCULAR CENTER&lt;/strong&gt;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Khlynova</surname><given-names>Olga V.</given-names></name><name xml:lang="en"><surname>Khlynova</surname><given-names>Olga V.</given-names></name></name-alternatives><email>olgakhlynova@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Shishkina</surname><given-names>Ekaterina A.</given-names></name><name xml:lang="en"><surname>Shishkina</surname><given-names>Ekaterina A.</given-names></name></name-alternatives><email>doctor.shishkina@yandex.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Zubova</surname><given-names>M. A.</given-names></name><name xml:lang="en"><surname>Zubova</surname><given-names>M. A.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Abgaryan</surname><given-names>N. I.</given-names></name><name xml:lang="en"><surname>Abgaryan</surname><given-names>N. I.</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="epub"><year>2020</year></pub-date><volume>43</volume><issue>2</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/journal-medicine/2020/2/206-215.pdf" /><abstract xml:lang="ru"><p>Nowadays in real clinical practice there are a lot of patients with comorbidity. Based on these, the problem of comorbidity in patients with cardiovascular diseases attracts the attention of medical specialists. However, in the domestic medical journals there is no information about the presence and prognostic significance of concomitant diseases in patients with myocardial infarction (MI) of working age. The aim of our study was to&amp;nbsp;estimate the frequency of occurrence, gender and age characteristics of comorbidity in young and middle aged patients with MI and to present its prognostic significance. The study population consisted of 424 patients (median age of 50 (43.5; 55.0) years), treated in the regional vascular center of Perm city during the period of 2018&amp;ndash;2019. In addition to the standard clinical, instrumental and laboratory examination, the Charlson Comorbidity Index (CI) was calculated for every patient. In general, the rate of comorbidity in patients with MI was average (CI = 2.71 &amp;plusmn; 0.08 points), while the number of diseases was dependent on the patient&amp;lsquo;s age and gender. The statistically significant increase in CI was observed in patients older than 40 years (OR = 12.35; 95 % CI: 5.76&amp;ndash;26.46, p = 0.0001). The risk of recurring coronary events in patients with MI increased in those who had CI &amp;gt; 2 (OR = 2.59; 95 % CI: 1.11&amp;ndash;5.89, p = 0.027). If the CI was &amp;gt; 4, the level of post-hospital mortality had been increased (OR = 3.82; 95 % CI: 1.34&amp;ndash;10.91, p = 0.012).</p></abstract><trans-abstract xml:lang="en"><p>Nowadays in real clinical practice there are a lot of patients with comorbidity. Based on these, the problem of comorbidity in patients with cardiovascular diseases attracts the attention of medical specialists. However, in the domestic medical journals there is no information about the presence and prognostic significance of concomitant diseases in patients with myocardial infarction (MI) of working age. The aim of our study was to&amp;nbsp;estimate the frequency of occurrence, gender and age characteristics of comorbidity in young and middle aged patients with MI and to present its prognostic significance. The study population consisted of 424 patients (median age of 50 (43.5; 55.0) years), treated in the regional vascular center of Perm city during the period of 2018&amp;ndash;2019. In addition to the standard clinical, instrumental and laboratory examination, the Charlson Comorbidity Index (CI) was calculated for every patient. In general, the rate of comorbidity in patients with MI was average (CI = 2.71 &amp;plusmn; 0.08 points), while the number of diseases was dependent on the patient&amp;lsquo;s age and gender. The statistically significant increase in CI was observed in patients older than 40 years (OR = 12.35; 95 % CI: 5.76&amp;ndash;26.46, p = 0.0001). The risk of recurring coronary events in patients with MI increased in those who had CI &amp;gt; 2 (OR = 2.59; 95 % CI: 1.11&amp;ndash;5.89, p = 0.027). If the CI was &amp;gt; 4, the level of post-hospital mortality had been increased (OR = 3.82; 95 % CI: 1.34&amp;ndash;10.91, p = 0.012).</p></trans-abstract><kwd-group xml:lang="ru"><kwd>myocardial infarction</kwd><kwd>young age</kwd><kwd>comorbidity</kwd><kwd>gender characteristics</kwd><kwd>prognostic value</kwd></kwd-group><kwd-group xml:lang="en"><kwd>myocardial infarction</kwd><kwd>young age</kwd><kwd>comorbidity</kwd><kwd>gender characteristics</kwd><kwd>prognostic value</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Barbarash O.L., Semjonov V.Yu., Samorodskaya I.V., Evseeva M.V., Rozhkov N.A., Sumin A.N., Barbarash L.S. 2017. Komorbidnaya patologiya u bol&amp;#39;nyh ishemicheskoj bolezn&amp;#39;yu pri koronarnom shuntiro-vanii: opyt dvuh kardiohirurgicheskih centrov [Comorbitidy in coronary heart disease patients undergoing bypass grafting: an experience of two surgery centers]. Rossijskij kardiologicheskij zhurnal, 3 (143): 6&amp;ndash;13.</mixed-citation></ref><ref id="B2"><mixed-citation>Dedov I.I., Shestakova M.V., Vikulova O.K. 2015. Gosudarstvennyi registr sakharnogo dia-beta v Rossiiskoi Federatsii: status 2014 g. i perspektivy razvitiia [National register of diabetes mellitus in Russian Federation:status on 2014]. Sakharnyi diabet, 3 (18): 5&amp;ndash;22.</mixed-citation></ref><ref id="B3"><mixed-citation>Efanov A.Y., Storozhok М.A., Sholomov I.F., Medvedeva I.V., Shalaev S.V. 2016. Raspros-tranennost&amp;#39; faktorov riska serdcheno-sosudistyh zabolevanij v neorganizovannoj populyacii zhitelej Tyu-menskogo regiona 25&amp;ndash;64 let. Rezul&amp;#39;taty issledovaniya ESSE-RF v Tyumenskom regione [Prevalence of cardiovascular risk factors in non-organized population of 25&amp;ndash;64 years old in Tyumen region. Results of ESSE-RF Study in Tyumen region]. Kardiovaskulyarnaya terapiya i profilaktika, 15(4): 60&amp;ndash;65.</mixed-citation></ref><ref id="B4"><mixed-citation>Zhernakova Yu.V., Chazova I.E. 2016. Upravlenie serdechno-sosudistymi riskami u bol&amp;#39;nyh saharnym diabetom [Control of cardiovascular risk in patients with diabetes]. Sistemnye gipertenzii, 13 (3): 42&amp;ndash;47.</mixed-citation></ref><ref id="B5"><mixed-citation>Koval&amp;#39;chuk E.Yu., Soroka V.V. 2015. Sovremennyj kliniko-epidemiologicheskij portert pa-cienta s ostrym infarktom miokarda (po materialam regional&amp;#39;nogo sosudistogo centra). Uchenye zapiski SPbGMU im. akademika I.P. Pavlova, 2 (22): 56&amp;ndash;60.</mixed-citation></ref><ref id="B6"><mixed-citation>Kochergina A.M., Karetnikova V.N., Barbarash O.L. 2016. Gendernye razlichiya faktorov kar-diovaskulyarnogo riska u pacientov raznyh vozrastnyh grupp (po dannym issledovaniya ESSE-RF) [Gender-specific differences of cardiovascular risk factors in different age groups]. Medicina v Kuzbasse, (1): 75&amp;ndash;82.</mixed-citation></ref><ref id="B7"><mixed-citation>Kuznecov V.A., Bessonov I.S., Pushkarev G.S., Musihina N.A., Gul&amp;#39;tyaeva E.P., Zyryanov I.P., Gorbatenko E.A., Sapozhnikov S.S. 2015. Prospektivnyj registr chreskozhnyh koronarnyh vmeshatel&amp;#39;stv: opyt Tyumenskogo kardiologicheskogo centra [Prospective registry of percutaneous coronary interventions: Tyu-men Cardiology Center&amp;lsquo;s Experience]. Patologiya krovoobrashcheniya i kardiohirurgiya, 19(3): 80&amp;ndash;86.</mixed-citation></ref><ref id="B8"><mixed-citation>Maksimov S.A., Indukaeva E.V., Skripchenko A.E., Cherkass N.V., Pavlova S.V., Artamon-ova G.V. 2014. Rasprostranyonnost&amp;#39; osnovnyh faktorov serdechno-sosudistogo riska v Kemerovskoj ob-lasti: rezul&amp;#39;taty mnogocentrovogo epidemiologicheskogo issledovaniya ESSE-RF [Prevalence of major factors of cardiovascular resk in Kemerovo region: results of multicenter epidemiological research ECVE-RF]. Medicina v Kuzbasse, (3): 36&amp;ndash;42.</mixed-citation></ref><ref id="B9"><mixed-citation>Malaj L.N., Davidovich I.M. 2017. Habarovskij registr ostrogo infarkta miokarda: analiz otdalennyh iskhodov i priverzhennosti dlitel&amp;#39;noj medikamentoznoj terapii [Khabarovsk register of acute myocardial infarction: the analysis of long-term prognosis and long-term medical treatment compliance]. Dal&amp;#39;nevostochnyj medicinskij zhurnal, 2: 43&amp;ndash;48.</mixed-citation></ref><ref id="B10"><mixed-citation>Nizov A.A., Suchkova E.I., Dashkevich O.V., Trunina T.P. 2019. Kardiovaskulyarnaya komor-bidnost&amp;#39; v real&amp;#39;noj klinicheskoj praktike ambulatornogo vracha. Sravnitel&amp;#39;noe registrovoe issledovanie v Rya-zanskoj oblasti [Cardiovascular comorbidity in the real clinical practice of an ambulatory physician. Compara-tive register research in the Ryazan region]. Kardiovaskulyarnaya terapiya i profilaktika, 18(2): 70&amp;ndash;75.</mixed-citation></ref><ref id="B11"><mixed-citation>Novikova I.A., Nekrutenko L.A., Lebedeva T.M., Khlynova O.V., Shishkina E.A. 2019. Pa-cient posle infarkta miokarda: faktory riska novyh serdechno-sosudistyh katastrof [Patient after cardiac infarction: risk factors that can cause new cardiovascular disasters]. Analiz riska zdorov&amp;#39;yu, 1: 135&amp;ndash;143.</mixed-citation></ref><ref id="B12"><mixed-citation>Popov S.V., Garganeeva A.A., Borel&amp;#39; K.N., Kuzheleva E.A., Okrugin S.A. 2016. Infarkt mi-okarda u pacientov molodogo vozrasta: mnogoletnij sravnitel&amp;#39;nyj analiz osobennostej razvitiya, klinich-eskogo techeniya i strategii vedeniya [Myocardial infarction in young patients: long-term analysis of specificity of appearance, clinical course and strategies of management]. Kompleksnye problemy ser-dechno-sosudistyh zabolevanij, 4: 66&amp;ndash;72.</mixed-citation></ref><ref id="B13"><mixed-citation>Sumin A.N., Korok E.V., Shcheglova A.V., Barbarash O.L. 2017. Komorbidnost&amp;#39; u bol&amp;#39;nyh ishemicheskoj bolezn&amp;#39;yu serdca: gendernye osobennosti [Comorbidities in patients with ischemic heart disease]. Racional&amp;#39;naya Farmakoterapiya v Kardiologii, 13(5): 622&amp;ndash;629.</mixed-citation></ref><ref id="B14"><mixed-citation>Chichkova M.A., Zav&amp;#39;yalov B.G., Chichkov Yu.M., Kozlova O.S., Chichkov A.M., Kadi-ev G.M. 2019. Vliyanie komorbidnoj patologii i kliniko-prognosticheskih faktorov na iskhody infarkta&amp;nbsp;miokarda u pacientov pozhilogo i starcheskogo vozrasta [The effect of comorbid pathology and clinical and prognostic factors on the outcome of myocardial infarction in elderly and senile patients]. Astrahanskij medicinskij zhurnal, 14 (1): 101&amp;ndash;107.</mixed-citation></ref><ref id="B15"><mixed-citation>Canivell S., Muller O., Gencer B., Heg D., Klingenberg R., R&amp;auml;ber L., Carballo D., Mat-ter Ch., L&amp;uuml;scher T., Windecker S., Mach F., Rodoni N., Nanchen D. 2018. Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome. PLoS ONE 13(4): e0195174.</mixed-citation></ref><ref id="B16"><mixed-citation>Charlson M., Pompei P., Ales K.L., MacKenzie C.R. 1987. A new method of classifying prog-nostic comorbidity in longitudinal studies: development and validation. J. Chronic. Dis. 40(5): 373&amp;ndash;83.</mixed-citation></ref><ref id="B17"><mixed-citation>Hajat С., Stein E. 2018. The global burden of multiple chronic conditions: A narrative re-view. Preventive Medicine Reports, 12: 284&amp;ndash;293.</mixed-citation></ref><ref id="B18"><mixed-citation>Hall M., Dondo T., Yan A., Mamas M., Timmis A., Deanfield J., Jernberg T., Hemingway H., Fox K., Gale C. 2018. Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: Latent class analysis of a nationwide population-based cohort. PLoS Med., 15 (3): e1002501.</mixed-citation></ref><ref id="B19"><mixed-citation>Jani B., Hanlon P., Nicholl B., McQueenie R., Gallacher K., Lee D., Mair F. 2019. Relation-ship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort. BMC Med., 17 (1): 74.</mixed-citation></ref><ref id="B20"><mixed-citation>Marel C., Mills K. 2017. The importance of identifying, managing, and appropriately treat-ing comorbidity in young people. Advances in Dual Diagnosis. 10 (4): 125&amp;ndash;129.</mixed-citation></ref><ref id="B21"><mixed-citation>Navickas R., Petric V., Feigl A., Seychell M. 2016. Multimorbidity: What do we know? What should we do? J. Comorbidity, 6: 4&amp;ndash;11.</mixed-citation></ref><ref id="B22"><mixed-citation>Nunes B., Flores T., Mielke G., Thume E., Facchini L. 2016. Multimorbidity and mortality in older adults: A systematic review and meta-analysis. Arch. Gerontol. Geriatr., 67: 130&amp;ndash;138.</mixed-citation></ref><ref id="B23"><mixed-citation>Ofori-Asenso R., Zomer E., Markey P., Si S., Ademi Z, Curtis A., Zoungas S., Liew D. 2019. Prevalence and impact of non-cardiovascular comorbidities among older adults hospitalized for non-ST segment elevation acute coronary syndrome. Cardiovasc. Diagn. Ther., 9 (3): 250&amp;ndash;261.</mixed-citation></ref><ref id="B24"><mixed-citation>Prados-Torres A., Poblador-Plou B., Gimeno-Miguel A., Calder&amp;oacute;n-Larra&amp;ntilde;aga A., Poncel-Falc&amp;oacute; A., Gimeno-Feli&amp;uacute; L., Gonz&amp;aacute;lez-Rubio F., Laguna-Berna C., Marta-Moreno J., Clerencia-Sierra M., Aza-Pascual-Salcedo M., Bandr&amp;eacute;s-Liso A., Coscollar-Santaliestra C., Pico-Soler V., Abad-D&amp;iacute;ez J. 2018. Cohort Profile: The Epidemiology of Chronic Diseases and Multimorbidity. The EpiChron. Cohort. Study. International Journal of Epidemiology, 47 (2): 382&amp;ndash;384.</mixed-citation></ref><ref id="B25"><mixed-citation>Radovanovic D., Seifert B., Urban P., Eberli F., Rickli H., Bertel O., Erne P. 2013. Charlson Comorbidity Index in patients hospitalized with acute coronary syndrome, European Heart Journal, 34 (1): 3122.</mixed-citation></ref><ref id="B26"><mixed-citation>Tisminetzky M., Gurwitz J., Miozzo R., Gore J., Lessard D., Yarzebski J., Goldberg R. 2019. Impact of cardiac- and noncardiac-related conditions on adverse outcomes in patients hospitalized with acute myocardial infarction. J. Comorb., 9: 2235042X19852499.</mixed-citation></ref><ref id="B27"><mixed-citation>Tran J., Norton R., Conrad N., Rahimian F., Canoy D., Nazarzadeh M., Rahimi K. 2018. Pat-terns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: A population-based cohort study. PLoS Med. 15 (3): e1002513.</mixed-citation></ref></ref-list></back></article>